Specific immunotherapy in the treatment of atopic dermatitis: A systematic review using the GRADE system

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 6, 2013, Pages 555-561

  Gendelman, Samantha R ^a   Lang, David M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; HOUSE DUST ALLERGEN; PLACEBO; POLLEN ANTIGEN; STEROID;

ANTIGEN ANTIBODY COMPLEX; ATOPIC DERMATITIS; DESENSITIZATION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOTHERAPY; INTRACUTANEOUS TEST; MAINTENANCE DRUG DOSE; PERSONAL HYGIENE; PRICK TEST; PRIORITY JOURNAL; REVIEW; SKIN TEST; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW;

EID: 84888644510     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.08.020     Document Type: Article

References (36)

1. T. Habif Atopic dermatitis C. Bonnett, S. Pinczewski, L. Cook, B. Welch, Clinical Dermatology: A Color Guide to Diagnosis and Therapy 5th ed 2010 Elsevier London 155
2. R.A. Tupker, J.G. De Monchy, P.J. Coenraads, A. Homan, and J.B. van der Meer Induction of atopic dermatitis by inhalation of house dust mite J Allergy Clin Immunol 97 1996 1064 1070
3. B.B. Tan, D. Weald, I. Strickland, and P.S. Friedmann Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis Lancet 347 1996 15 18
4. L. Holm, A. Bengtsson, M. van Hage-Hamsten, S. Ohman, and A. Scheynius Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration Allergy 56 2001 152 158
5. L. Noon Prophylactic inoculation against hay fever Lancet 1 1911 1572 1573
6. L. Cox, H. Nelson, and R. Lockey Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 2011 S1 55
7. M.J. Abramson, R.M. Puy, and J.M. Weiner Injection allergen immunotherapy for asthma Cochrane Database Syst Rev 8 2010 CD001186
8. L. Schneider, S. Tilles, and P. Lio Atopic dermatitis: a practice parameter update 2012 J Allergy Clin Immunol 131 2013 295 299 e1-27
9. C. Bussmann, A. Bockenhoff, H. Henke, T. Werfel, and N. Novak Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118 2006 1292 1298
10. E. Compalati, A. Rogkakou, G. Passalacqua, and G.W. Canonica Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review Curr Opin Allergy Clin Immunol 12 2012 427 433
11. D. Atkins, M. Eccles, and S. Flottorp Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE Working Group BMC Health Serv Res 4 2004 38
12. J.L. Brozek, E.A. Akl, and P. Alonso-Coello Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions Allergy 64 2009 669 677
13. G.H. Guyatt, A.D. Oxman, and G.E. Vist GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
14. G.B. Pajno, L. Caminiti, and D. Vita Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study J Allergy Clin Immunol 120 2007 164 170
15. T. Werfel, K. Breuer, and F. Rueff Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study Allergy 61 2006 202 205
16. M.T. Glover, and D.J. Atherton A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema Clin Exp Allergy 22 1992 440 446
17. H.S. Kaufman, and H.L. Roth Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study Ann Allergy 32 1974 321 330
18. B.P. Leroy, G. Boden, J.M. Lachapelle, M.G. Jacquemin, and J.M. Saint-Remy A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study J Am Acad Dermatol 28 1993 232 239
19. J. Ring Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins Br J Dermatol 107 1982 597 602
20. N. Novak, T. Bieber, and M. Hoffmann Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis J Allergy Clin Immunol 130 2012 925 931.e4
21. Anonymous severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis Dermatology 186 1993 23 31
22. A.P. Oranje Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score Curr Probl Dermatol 41 2011 149 155
23. M.E. Schram, P.I. Spuls, M.M. Leeflang, R. Lindeboom, J.D. Bos, and J. Schmitt EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference Allergy 67 2012 99 106
24. H.L. Elliott Post hoc analysis: use and dangers in perspective J Hypertens Suppl 14 1996 S21 S24 discussion S24-25
25. P.A. Eng, M. Borer-Reinhold, I.A. Heijnen, and H.P. Gnehm Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 2006 198 201
26. P.A. Eng, M. Reinhold, and H.P. Gnehm Long-term efficacy of preseasonal grass pollen immunotherapy in children Allergy 57 2002 306 312
27. L. Jacobsen Preventive aspects of immunotherapy: prevention for children at risk of developing asthma Ann Allergy Asthma Immunol 87 2001 43 46
28. A. Des Roches, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daures, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
29. G.B. Pajno, G. Barberio, F. De Luca, L. Morabito, and S. Parmiani Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study Clin Exp Allergy 31 2001 1392 1397
30. A. Inal, D.U. Altintas, M. Yilmaz, G.B. Karakoc, S.G. Kendirli, and Y. Sertdemir Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite J Investig Allergol Clin Immunol 17 2007 85 91
31. R. Evans, H. Pence, H. Kaplan, and R.E. Rocklin The effect of immunotherapy on humoral and cellular responses in ragweed hayfever J Clin Invest 57 1976 1378 1385
32. C.U. Tuazon, and J.N. Sheagren Increased rate of carriage of Staphylococcus aureus among narcotic addicts J Infect Dis 129 1974 725 727
33. C.U. Tuazon, A. Perez, T. Kishaba, and J.N. Sheagren Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate JAMA 231 1975 1272
34. N. Kirmani, C.U. Tuazon, and D. Alling Carriage rate of Staphylococcus aureus among patients receiving allergy injections Ann Allergy 45 1980 235 237
35. T.J. Guzik, M. Bzowska, and A. Kasprowicz Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters Clin Exp Allergy 35 2005 448 455
36. G.H. Guyatt, A.D. Oxman, and R. Kunz GRADE guidelines: 7. Rating the quality of evidence - inconsistency J Clin Epidemiol 64 2011 1294 1302